Cresset Asset Management, LLC 10x Genomics, Inc. Transaction History

Cresset Asset Management, LLC

$17.3 Billion
Q4 2024

A detailed history of Cresset Asset Management, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 41,619 shares of TXG stock, worth $512,746. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,619

Previous 136,921 69.6%

Holding current value

$512,746

Previous $3.09 Million 80.69%

% of portfolio

0.0%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$13.18 - $21.31 $1.26 Million - $2.03 Million	-95,302 Reduced 69.6%	41,619 $597,000
Q3 2024 Nov 14, 2024	BUY	$15.71 - $23.49 $954,759 - $1.43 Million	60,774 Added 79.81%	136,921 $3.09 Million
Q2 2024 Aug 14, 2024	BUY	$19.45 - $37.37 $341,211 - $655,581	17,543 Added 29.93%	76,147 $1.48 Million
Q1 2024 May 15, 2024	SELL	$36.08 - $54.3 $86,519 - $130,211	-2,398 Reduced 3.93%	58,604 $2.2 Million
Q4 2023 Feb 14, 2024	BUY	$34.32 - $57.55 $347,490 - $582,693	10,125 Added 19.9%	61,002 $3.41 Million
Q3 2023 Nov 14, 2023	SELL	$40.86 - $62.98 $183,951 - $283,535	-4,502 Reduced 8.13%	50,877 $2.1 Million
Q2 2023 Aug 14, 2023	BUY	$50.96 - $58.72 $2.82 Million - $3.25 Million	55,379 New	55,379 $3.09 Million
Q4 2021 Feb 10, 2022	SELL	$135.05 - $182.59 $548,032 - $740,950	-4,058 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$145.58 - $192.14 $95,646 - $126,235	-657 Reduced 13.93%	4,058 $590,000
Q2 2021 Aug 10, 2021	SELL	$134.22 - $202.37 $146,165 - $220,380	-1,089 Reduced 18.76%	4,715 $924,000
Q1 2021 May 12, 2021	BUY	$140.25 - $196.86 $814,011 - $1.14 Million	5,804 New	5,804 $1.05 Million

Others Institutions Holding TXG

# of Institutions

294

Shares Held

95.4M

Call Options Held

242K

Put Options Held

116K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.17B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.

Account

Cresset Asset Management, LLC 10x Genomics, Inc. Transaction History